Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.
Clinical trial NCT05860595 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05860595
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-23
- Primary completion
- 2025-08-20
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.